Adrenomedullin and cancer

Regulatory Peptides

Volumn 112, Issue 1-3, 2003, Pages 175-183

  Zudaire, E ^a   Martinez A ^a   Cuttitta, F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; BINDING PROTEIN; COMPLEMENT FACTOR H; CYTOKINE; HYPOXIA INDUCIBLE FACTOR 1;

APOPTOSIS; AUTOCRINE EFFECT; CANCER; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; HYPOXIA; IMMUNE RESPONSE; INFLAMMATION; KIDNEY DISEASE; NEOVASCULARIZATION (PATHOLOGY); PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; TUMOR GROWTH; UPREGULATION;

EID: 0037445799     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(03)00037-5     Document Type: Review

References (114)

1. Wimalawansa S.J. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit. Rev. Neurobiol. 11(2-3):1997;167-239.
2. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H.et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192(2):1993;553-560.
3. Hinson J.P., Thomson L.M., Kapas S. Adrenomedullin and CGRP receptors mediate different effects in the rat adrenal cortex. Endocr. Res. 24(3-4):1998;725-728.
4. Lopez J., Martinez A. Cell and molecular biology of the multifunctional peptide, adrenomedullin. Int. Rev. Cytol. 221:2002;1-92.
5. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100(1):2000;57-70.
6. Satoh F., Takahashi K., Murakami O., Totsune K., Sone M., Ohneda M.et al. Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma. J. Clin. Endocrinol. Metab. 80(5):1995;1750-1752.
7. Zimmermann U., Fischer J.A., Frei K., Fischer A.H., Reinscheid R.K., Muff R. Identification of adrenomedullin receptors in cultured rat astrocytes and in neuroblastboma×glioma hybrid cells (NG108-15). Brain Res. 724(2):1996;238-245.
8. Martinez A., Miller M.J., Unsworth E.J., Siegfried J.M., Cuttitta F. Expression of adrenomedullin in normal human lung and in pulmonary tumors. Endocrinology. 136(9):1995;4099-4105.
9. Miller M.J., Martinez A., Unsworth E.J., Thiele C.J., Moody T.W., Elsasser T.et al. Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. J. Biol. Chem. 271(38):1996;23345-23351.
10. Ouafik L., Sauze S., Boudouresque F., Chinot O., Delfino C., Fina F.et al. Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. Am. J. Pathol. 160(4):2002;1279-1292.
11. Oehler M.K., Hague S., Rees M.C., Bicknell R. Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis. Oncogene. 21(18):2002;2815-2821.
12. Martinez A., Vos M., Guedez L., Kaur G., Chen Z.et al. The effects of adrenomedullin overexpression in breast tumor cells. J. Natl. Cancer Inst. 94:2002;1226-1237.
13. Njuki F., Nicholl C.G., Howard A., Mak J.C., Barnes P.J., Girgis S.I.et al. A new calcitonin-receptor-like sequence in rat pulmonary blood vessels. Clin. Sci. (Colch.). 85(4):1993;385-388.
14. Harrison J.K., Barber C.M., Lynch K.R. Molecular cloning of a novel rat G-protein-coupled receptor gene expressed prominently in lung, adrenal, and liver. FEBS Lett. 318(1):1993;17-22.
15. Kapas S., Catt K.J., Clark A.J. Cloning and expression of cDNA encoding a rat adrenomedullin receptor. J. Biol. Chem. 270(43):1995;25344-25347.
16. Eva C., Sprengel R. A novel putative G protein-coupled receptor highly expressed in lung and testis. DNA Cell Biol. 12(5):1993;393-399.
17. Libert F., Parmentier M., Lefort A., Dumont J.E., Vassart G. Complete nucleotide sequence of a putative G protein coupled receptor: RDC1. Nucleic Acids Res. 18(7):1990;1917.
18. Hanze J., Dittrich K., Dotsch J., Rascher W. Molecular cloning of a novel human receptor gene with homology to the rat adrenomedullin receptor and high expression in heart and immune system. Biochem. Biophys. Res. Commun. 240(1):1997;183-188.
19. Hanze J., Groneberg D.A., Rose F., Hanisch A., Dotsch J., Peiser C.et al. Genomic organization and regulation of a human 7-helix transmembrane receptor which is expressed in pulmonary epithelial cells and induced in hypoxia. Biochem. Biophys. Res. Commun. 291(5):2002;1160-1165.
20. Kennedy S.P., Sun D., Oleynek J.J., Hoth C.F., Kong J., Hill R.J. Expression of the rat adrenomedullin receptor or a putative human adrenomedullin receptor does not correlate with adrenomedullin binding or functional response. Biochem. Biophys. Res. Commun. 244(3):1998;832-837.
21. Muff R., Born J.A., Fischer J.A. Adrenomedullin and related peptides: receptors and accesory proteins. Peptides. 22(11):2001;1765-1772.
22. Hay D.L., Smith D.M. Adrenomedullin receptors: molecular identity and function. Peptides. 22(11):2001;1753-1763.
23. Marinissen M.J., Gutkind J.S. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol. Sci. 22(7):2001;368-376.
24. Poyner D.R. Molecular pharmacology of receptors for calcitonin-gene-related peptide, amylin and adrenomedullin. Biochem. Soc. Trans. 25(3):1997;1032-1036.
25. Muff R., Born W., Fischer J.A. Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions. Eur. J. Endocrinol. 133(1):1995;17-20.
26. Muff R., Born W., Fischer J.A. Receptors for calcitonin, calcitonin gene related peptide, amylin, and adrenomedullin. Can. J. Physiol. Pharmacol. 73(7):1995;963-967.
27. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N.et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 393(6683):1998;333-339.
28. Muff R., Leuthauser K., Buhlmann N., Foord S.M., Fischer J.A., Born W. Receptor activity modifying proteins regulate the activity of a calcitonin gene-related peptide receptor in rabbit aortic endothelial cells. FEBS Lett. 441(3):1998;366-368.
29. Buhlmann N., Leuthauser K., Muff R., Fischer J.A., Born W. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1. Endocrinology. 140(6):1999;2883-2890.
30. Coppock H.A., Owji A.A., Austin C., Upton P.D., Jackson M.L., Gardiner J.V.et al. Rat-2 fibroblasts express specific adrenomedullin receptors, but not calcitonin-gene-related-peptide receptors, which mediate increased intracellular cAMP and inhibit mitogen-activated protein kinase activity. Biochem. J. 338(Pt. 1):1999;15-22.
31. Coppock H.A., Owji A.A., Bloom S.R., Smith D.M. A rat skeletal muscle cell line (L6) expresses specific adrenomedullin binding sites but activates adenylate cyclase via calcitonin gene-related peptide receptors. Biochem. J. 318(Pt. 1):1996;241-245.
32. Hinson J.P., Kapas S., Smith D.M. Adrenomedullin, a multifunctional regulatory peptide. Endocr. Rev. 21(2):2000;138-167.
33. Iwasaki H., Eguchi S., Shichiri M., Marumo F., Hirata Y. Adrenomedullin as a novel growth-promoting factor for cultured vascular smooth muscle cells: role of tyrosine kinase-mediated mitogen-activated protein kinase activation. Endocrinology. 139(8):1998;3432-3441.
34. Barker S., Lees D.M., Wood E.G., Corder R. Inhibitory effect of adrenomedullin on basal and tumour necrosis factor alpha-stimulated endothelin-1 synthesis in bovine aortic endothelial cells is independent of cyclic AMP. Biochem. Pharmacol. 63(2):2002;149-156.
35. G-nitro L-arginine but not glibenclamide. Br. J. Pharmacol. 115(6):1995;917-924.
36. Hayakawa H., Hirata Y., Kakoki M., Suzuki Y., Nishimatsu H., Nagata D.et al. Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilation in the rat. Hypertension. 33(2):1999;689-693.
37. Haneda M., Araki S., Sugimoto T., Togawa M., Koya D., Kikkawa R. Differential inhibition of mesangial MAP kinase cascade by cyclic nucleotides. Kidney Int. 50(2):1996;384-391.
38. Chini E.N., Choi E., Grande J.P., Burnett J.C., Dousa T.P. Adrenomedullin suppresses mitogenesis in rat mesangial cells via cAMP pathway. Biochem. Biophys. Res. Commun. 215(3):1995;868-873.
39. Togawa M., Haneda M., Araki S., Sugimoto T., Isono M., Hidaka H.et al. Beraprost sodium, an analogue of prostacyclin, induces the expression of mitogen-activated protein kinase phosphatase and inhibits the proliferation of cultured mesangial cells. Eur. J. Pharmacol. 336(2-3):1997;291-294.
40. Cuttitta F., Montuenga L.M., Garayoa M., Pio R., Miller M.J., Walsh T.et al. The role of adrenomedullin as a growth regulatory peptide in the normal and malignant setting. J. Anim. Sci. 77(Suppl. 3):1999;55-69.
41. Sakai K., Saito K., Ishizuka N. Adrenomedullin synergistically interacts with endogenous vasodilators in rats: a possible role of K(ATP) channels. Eur. J. Pharmacol. 359(2-3):1998;151-159.
42. Giatromanolaki A., Harris A.L. Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer. Anticancer Res. 21(6B):2001;4317-4324.
43. Wenger R.H., Gassmann M. Oxygen(es) and the hypoxia-inducible factor-1. Biol. Chem. 378(7):1997;609-616.
44. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. U. S. A. 95(14):1998;7987-7992.
45. Bunn H.F., Gu J., Huang L.E., Park J.W., Zhu H. Erythropoietin: a model system for studying oxygen-dependent gene regulation. J. Exp. Biol. 201(Pt. 8):1998;1197-1201.
46. Rolfs A., Kvietikova I., Gassmann M., Wenger R.H. Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J. Biol. Chem. 272(32):1997;20055-20062.
47. Wang X., Yue T.L., Barone F.C., White R.F., Clark R.K., Willette R.N.et al. Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage. Proc. Natl. Acad. Sci. U. S. A. 92(25):1995;11480-11484.
48. Dogan A., Suzuki Y., Koketsu N., Osuka K., Saito K., Takayasu M.et al. Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 17(1):1997;19-25.
49. Feuerstein G.Z., Wang X. Use of differential display reverse transcription-polymerase chain reaction for discovery of induced adrenomedullin gene expression in focal stroke. Can. J. Physiol. Pharmacol. 75(6):1997;731-734.
50. Kitamuro T., Takahashi K., Nakayama M., Murakami O., Hida W., Shirato K.et al. Induction of adrenomedullin during hypoxia in cultured human glioblastoma cells. J. Neurochem. 75(5):2000;1826-1833.
51. Ladoux A., Frelin C. Coordinated up-regulation by hypoxia of adrenomedullin and one of its putative receptors (RDC-1) in cells of the rat blood-brain barrier. J. Biol. Chem. 275(51):2000;39914-39919.
52. Serrano J., Alonso D., Encinas J.M., Lopez J.C., Fernandez A.P., Castro-Blanco S.et al. Adrenomedullin expression is up-regulated by ischemia-reperfusion in the cerebral cortex of the adult rat. Neuroscience. 109(4):2002;717-731.
53. Watanabe K., Takayasu M., Noda A., Hara M., Takagi T., Suzuki Y.et al. Adrenomedullin reduces ischemic brain injury after transient middle cerebral artery occlusion in rats. Acta Neurochir. (Wien). 143(11):2001;1157-1161.
54. Zhao L., Brown L.A., Owji A.A., Nunez D.J., Smith D.M., Ghatei M.A.et al. Adrenomedullin activity in chronically hypoxic rat lungs. Am. J. Physiol. 271(2 Pt. 2):1996;H622-H629.
55. Cheung B., Leung R. Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders. Clin. Sci. (Colch.). 92(1):1997;59-62.
56. Nakayama M., Takahashi K., Murakami O., Shirato K., Shibahara S. Induction of adrenomedullin by hypoxia and cobalt chloride in human colorectal carcinoma cells. Biochem Biophys. Res. Commun. 243:1998;514-517.
57. Mishra R.R., Adhikary G., Simonson M.S., Cherniack N.S., Prabhakar N.R. Role of c-fos in hypoxia-induced AP-1 cis-element activity and tyrosine hydroxylase gene expression. Brain Res., Mol. Brain Res. 59(1):1998;74-83.
58. Cormier-Regard S., Nguyen S.V., Claycomb W.C. Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J. Biol. Chem. 273(28):1998;17787-17792.
59. Nguyen S.V., Claycomb W.C. Hypoxia regulates the expression of the adrenomedullin and HIF-1 genes in cultured HL-1 cardiomyocytes. Biochem. Biophys. Res. Commun. 265(2):1999;382-386.
60. Yoshihara F., Horio T., Nishikimi T., Matsuo H., Kangawa K. Possible involvement of oxidative stress in hypoxia-induced adrenomedullin secretion in cultured rat cardiomyocytes. Eur. J. Pharmacol. 436(1-2):2002;1-6.
61. Kato J., Kobayashi K., Etoh T., Tanaka M., Kitamura K., Imamura T.et al. Plasma adrenomedullin concentration in patients with heart failure. J. Clin. Endocrinol. Metab. 81(1):1996;180-183.
62. Nishikimi T., Horio T., Sasaki T., Yoshihara F., Takishita S., Miyata A.et al. Cardiac production and secretion of adrenomedullin are increased in heart failure. Hypertension. 30(6):1997;1369-1375.
63. Jougasaki M., Stevens T.L., Borgeson D.D., Luchner A., Redfield M.M., Burnett J.C. Jr. Adrenomedullin in experimental congestive heart failure: cardiorenal activation. Am. J. Physiol. 273(4 Pt. 2):1997;R1392-R1399.
64. Ogita T., Hashimoto E., Yamasaki M., Nakaoka T., Matsuoka R., Kira Y.et al. Hypoxic induction of adrenomedullin in cultured human umbilical vein endothelial cells. J. Hypertens. 19(3 Pt. 2):2001;603-608.
65. Udono T., Takahashi K., Nakayama M., Yoshinoya A., Totsune K., Murakami O.et al. Induction of adrenomedullin by hypoxia in cultured retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 42(5):2001;1080-1086.
66. Garayoa M., Martinez A., Lee S., Pio R., An W.G., Neckers L.et al. Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol. Endocrinol. 14(6):2000;848-862.
67. Qing X., Svaren J., Keith I.M. mRNA expression of novel CGRP1 receptors and their activity-modifying proteins in hypoxic rat lung. Am. J. Physiol., Lung Cell. Mol. Physiol. 280(3):2001;L547-L554.
68. Kitamuro T., Takahashi K., Totsune K., Nakayama M., Murakami O., Hida W.et al. Differential expression of adrenomedullin and its receptor component, receptor activity modifying protein (RAMP) 2 during hypoxia in cultured human neuroblastoma cells. Peptides. 22(11):2001;1795-1801.
69. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86(3):1996;353-364.
70. Bouck N., Stellmach V., Hsu S.C. How tumors become angiogenic. Adv. Cancer Res. 69:1996;135-174.
71. Papetti M., Herman I.M. Mechanisms of normal and tumor-derived angiogenesis. Am. J. Physiol., Cell Physiol. 282(5):2002;C947-C970.
72. Parangi S., O'Reilly M., Christofori G., Holmgren L., Grosfeld J., Folkman J.et al. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc. Natl. Acad. Sci. U. S. A. 93(5):1996;2002-2007.
73. Folkman J. Tumor angiogenesis. Holland J.F., Bast R.C., Morton D.L., Frei E., Kufe D.W., Weichselbaum R.R. Cancer medicine. 1997;181-204 Williams & Wilkins, Baltimore.
74. Zhao Y., Hague S., Manek S., Zhang L., Bicknell R., Rees M.C. PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium. Oncogene. 16(3):1998;409-415.
75. Hague S., Zhang L., Oehler M.K., Manek S., MacKenzie I.Z., Bicknell R.et al. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density. Clin. Cancer Res. 6(7):2000;2808-2814.
76. Rees M., Hague S., Oehler M.K., Bicknell R. Regulation of endometrial angiogenesis. Climacteric. 2(1):1999;52-58.
77. Nikitenko L.L., MacKenzie I.Z., Rees M.C., Bicknell R. Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium. Mol. Hum. Reprod. 6(9):2000;811-819.
78. Kato H., Shichiri M., Marumo F., Hirata Y. Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells. Endocrinology. 138(6):1997;2615-2620.
79. Shichiri M., Kato H., Doi M., Marumo F., Hirata Y. Induction of max by adrenomedullin and calcitonin gene-related peptide antagonizes endothelial apoptosis. Mol. Endocrinol. 13(8):1999;1353-1363.
80. Sata M., Kakoki M., Nagata D., Nishimatsu H., Suzuki E., Aoyagi T.et al. Adrenomedullin and nitric oxide inhibit human endothelial cell apoptosis via a cyclic GMP-independent mechanism. Hypertension. 36(1):2000;83-88.
81. Oehler M.K., Norbury C., Hague S., Rees M.C., Bicknell R. Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth. Oncogene. 20(23):2001;2937-2945.
82. Rebuffat P., Forneris M.L., Aragona F., Ziolkowska A., Malendowicz L.K., Nussdorfer G.G. Adrenomedullin and its receptors are expressed in the zona glomerulosa of human adrenal gland: evidence that ADM enhances proliferation and decreases apoptosis in cultured ZG cells. Int. J. Mol. Med. 9(2):2002;119-124.
83. Kubo A., Minamino N., Isumi Y., Kangawa K., Dohi K., Matsuo H. Adrenomedullin production is correlated with differentiation in human leukemia cell lines and peripheral blood monocytes. FEBS Lett. 426(2):1998;233-237.
84. Kubo A., Minamino N., Isumi Y., Katafuchi T., Kangawa K., Dohi K.et al. Production of adrenomedullin in macrophage cell line and peritoneal macrophage. J. Biol. Chem. 273(27):1998;16730-16738.
85. Zaks-Zilberman M., Salkowski C.A., Elsasser T., Cuttitta F., Vogel S.N. Induction of adrenomedullin mRNA and protein by lipopolysaccharide and paclitaxel (Taxol) in murine macrophages. Infect. Immun. 66(10):1998;4669-4675.
86. Kamoi H., Kanazawa H., Hirata K., Kurihara N., Yano Y., Otani S. Adrenomedullin inhibits the secretion of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, from rat alveolar macrophages. Biochem. Biophys. Res. Commun. 211(3):1995;1031-1035.
87. Pio R., Martinez A., Unsworth E.J., Kowalak J.A., Bengoechea J.A., Zipfel P.F.et al. Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partners. J. Biol. Chem. 276(15):2001;12292-12300.
88. Fedarko N.S., Fohr B., Robey P.G., Young M.F., Fisher L.W. Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack. J. Biol. Chem. 275(22):2000;16666-16672.
89. Cuttitta F., Pio R., Garayoa M., Zudaire E., Julian M., Elsasser T.H.et al. Adrenomedullin functions as an important tumor survival factor in human carcinogenesis. Microsc. Res. Tech. 57(2):2002;110-119.
90. Ehlenz K., Koch B., Preuss P., Simon B., Koop I., Lang R.E. High levels of circulating adrenomedullin in severe illness: correlation with C-reactive protein and evidence against the adrenal medulla as site of origin. Exp. Clin. Endocrinol. Diabetes. 105(3):1997;156-162.
91. Michishita M., Minegishi T., Abe K., Kangawa K., Kojima M., Ibuki Y. Expression of adrenomedullin in the endometrium of the human uterus. Obstet. Gynecol. 93(1):1999;66-70.
92. Hata K., Takebayashi Y., Akiba S., Fujiwaki R., Iida K., Nakayama K.et al. Expression of the adrenomedullin gene in epithelial ovarian cancer. Mol. Hum. Reprod. 6(10):2000;867-872.
93. Rocchi P., Boudouresque F., Zamora A.J., Muracciole X., Lechevallier E., Martin P.M.et al. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines. Cancer Res. 61(3):2001;1196-1206.
94. Calvo A., Abasolo I., Jimenez N., Wang Z., Montuenga L. Adrenomedullin and proadrenomedullin N-terminal 20 peptide in the normal prostate and in prostate carcinoma. Microsc. Res. Tech. 57(2):2002;98-104.
95. Takahashi K., Satoh F., Hara E., Sone M., Murakami O., Kayama T.et al. Production and secretion of adrenomedullin from glial cell tumors and its effects on cAMP production. Peptides. 18(8):1997;1117-1124.
96. Knerr I., Schuster S., Nomikos P., Buchfelder M., Dotsch J., Schoof E.et al. Gene expression of adrenomedullin, leptin, their receptors and neuropeptide Y in hormone-secreting and non-functioning pituitary adenomas, meningiomas and malignant intracranial tumours in humans. Neuropathol. Appl. Neurobiol. 27(3):2001;215-222.
97. Zimmermann U., Fischer J.A., Muff R. Adrenomedullin and calcitonin gene-related peptide interact with the same receptor in cultured human neuroblastoma SK-N-MC cells. Peptides. 16(3):1995;421-424.
98. Spampinato S., Falcucci B., Cacciaguerra S., Campana G., Murari G. Characterization of a putative calcitonin receptor in IMR 32 human neuroblastoma cells. Neurosci. Lett. 273(3):1999;167-170.
99. Udono T., Totsune K., Takahashi K., Abe T., Sato M., Shibahara S.et al. Increased expression of adrenomedullin mRNA in the tissues of intraocular and orbital tumors. Am. J. Ophthalmol. 129(4):2000;555-556.
100. Dotsch J., Harmjanz A., Christiansen H., Hanze J., Lampert F., Rascher W. Gene expression of neuronal nitric oxide synthase and adrenomedullin in human neuroblastoma using real-time PCR. Int. J. Cancer. 88(2):2000;172-175.
101. Takahashi K., Satoh F., Hara E., Murakami O., Kumabe T., Tominaga T.et al. Production and secretion of adrenomedullin by cultured choroid plexus carcinoma cells. J. Neurochem. 68(2):1997;726-731.
102. Satoh F., Takahashi K., Murakami O., Totsune K., Sone M., Ohneda M.et al. Immunoreactive adrenomedullin in human adrenal glands and adrenal tumors. Cancer Detect. Prev. 21(1):1997;51-54.
103. Liu J., Kahri A.I., Heikkila P., Voutilainen R. Adrenomedullin gene expression and its different regulation in human adrenocortical and medullary tumors. J. Endocrinol. 155(3):1997;483-490.
104. Takahashi K., Satoh F., Sone M., Totsune K., Arihara Z., Noshiro T.et al. Expression of adrenomedullin mRNA in adrenocortical tumors and secretion of adrenomedullin by cultured adrenocortical carcinoma cells. Peptides. 19(10):1998;1719-1724.
105. Takahashi K., Yoshinoya A., Murakami O., Totsune K., Shibahara S. Production and secretion of two vasoactive peptides, adrenomedullin and endothelin-1, by cultured human adrenocortical carcinoma cells. Peptides. 21(2):2000;251-256.
106. Takahashi K., Yoshinoya A., Murakami O., Totsune K., Shibahara S. Secretion of endothelin-1 and adrenomedullin by SW-13 human adrenocortical carcinoma cells. J. Cardiovasc. Pharmacol. 36(5 Suppl. 1):2000;S393-S394.
107. Murakami O., Takahashi K., Satoh F., Totsune K., Sone M., Arihara Z.et al. Expression of adrenomedullin and adrenomedullin mRNA in ectopic ACTH-secreting tumors. Eur. J. Endocrinol. 138(4):1998;436-439.
108. Forneris M., Gottardo L., Albertin G., Malendowicz L.K., Nussdorfer G.G. Expression and function of adrenomedullin and its receptors in Conn's adenoma cells. Int. J. Mol. Med. 8(6):2001;675-679.
109. Albertin G., Forneris M., Aragona F., Nussdorfer G.G. Expression of adrenomedullin and its receptors in the human adrenal cortex and aldosteronomas. Int. J. Mol. Med. 8(4):2001;423-426.
110. Moriyama T., Otani T., Maruo T. Expression of adrenomedullin by human placental cytotrophoblasts and choriocarcinoma JAr cells. J. Clin. Endocrinol. Metab. 86(8):2001;3958-3961.
111. Nakayama M., Takahashi K., Kitamuro T., Murakami O., Shirato K., Shibahara S. Transcriptional control of adrenomedullin induction by phorbol ester in human monocytic leukemia cells. Eur. J. Biochem. 267(12):2000;3559-3566.
112. Martinez A., Elsasser T.H., Muro-Cacho C., Moody T.W., Miller M.J., Macri C.J.et al. Expression of adrenomedullin and its receptor in normal and malignant human skin: a potential pluripotent role in the integument. Endocrinology. 138(12):1997;5597-5604.
113. Kapas S., Brown D.W., Farthing P.M., Hagi-Pavli E. Adrenomedullin has mitogenic effects on human oral keratinocytes: involvement of cyclic AMP. FEBS Lett. 418(3):1997;287-290.
114. Moody T.W., Coy D., Cuttitta F., Montuenga L.M. Proadrenomedullin NH(2)-terminal 20 peptide (PAMP) and adrenomedullin bind to teratocarcinoma cells. Peptides. 21(1):2000;101-107.